about
Anti-HMGCR antibodies in systemic sclerosisTime to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.A review on SLE and malignancy.Patients with Active Luminal Crohn's Disease Have Evidence of Significant Functional and Clinical Pulmonary Involvement.Randomized controlled trials of biologic treatment with methotrexate in RA may not reflect real world practice: A systematic review and assessment of pragmaticismEditorial: Are Autoantibodies Involved in the Pathogenesis of Systemic Sclerosis?Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort
P50
Q36196309-0C795E0C-6AEF-4560-8AD5-5229EA8F5E69Q37984232-4558393B-233E-42DF-958E-144F57A97C66Q38834515-7AD149FB-BA84-4676-9F95-E6E243197E48Q47567556-9D1FD6E1-0C67-4042-8745-5DAA6970ED20Q51620685-03BC7B9E-BBA8-4BAF-9062-512800EA8B36Q59546269-E450D8CD-D048-40E1-9292-0B44AA4B950EQ89292446-741DE1EE-DF5D-429B-AF29-E11079E8D871Q90465816-FC9D6ABB-90B7-44CE-A831-0D6BEB7A1C7D
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
May Y Choi
@nl
May Y Choi
@sl
May Y. Choi
@en
May Y. Choi
@es
type
label
May Y Choi
@nl
May Y Choi
@sl
May Y. Choi
@en
May Y. Choi
@es
prefLabel
May Y Choi
@nl
May Y Choi
@sl
May Y. Choi
@en
May Y. Choi
@es
P106
P1153
57189602537
P21
P31
P496
0000-0003-3760-2737